Biotest AG (ETR:BIO) | Finanzwire

Basculer en Français

9474	Companies
185433	Keywords
117775	Articles
99293	Press releases

Home
Companies
Biotest AG

BRIEF

published on 10/02/2024 at 14:05, 1 year 2 months ago

Biotest AG Signs Strategic Agreement for Yimmugo® Distribution in the U.S.

Biotest AG U.S. Market Immunoglobulin Yimmugo® Kedrion Biopharma
PRESS RELEASE

published on 10/02/2024 at 14:00, 1 year 2 months ago

Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in July
Biotest AG finalized long-term distribution agreement with Kedrion for Yimmugo® in the United States, expecting over $1 billion in revenue. U.S. launch preparations underway

Distribution Agreement Biotest AG Yimmugo Kedrion $1 Billion Revenue
BRIEF

published on 09/12/2024 at 15:05, 1 year 2 months ago

Change in the Chief Financial Officer at Biotest AG

Chief Financial Officer Financial News Leadership Transition Biotest AG Martin Möller
PRESS RELEASE

published on 09/12/2024 at 15:00, 1 year 2 months ago

Change in the Chief Financial Officer at Biotest AG
Biotest AG announces change in Chief Financial Officer with Martin Moller taking over as Interim CFO. Ainhoa Mendizabal Zubiaga to step down for personal reasons

Chief Financial Officer Biotest AG Interim CFO Change Martin Möller
BRIEF

published on 09/05/2024 at 09:05, 1 year 3 months ago

Biotest AG Opens 13th Plasma Collection Center in Germany

Germany Patient Advocacy Biotest AG Plasma Collection Medical Treatments
PRESS RELEASE

published on 09/05/2024 at 09:00, 1 year 3 months ago

Biotest AG opens 13th plasma collection center in Germany
Biotest AG opens 13th plasma collection center in Germany to ensure long-term plasma supply. State-of-the-art center in Karlsruhe operated by Plasma Service Europe GmbH, a subsidiary of Biotest AG

Donations Germany Biotest AG Plasma Collection Center Plasma Service Europe GmbH
BRIEF

published on 08/28/2024 at 09:05, 1 year 3 months ago

Dr. Jörg Schüttrumpf Resigns from Biotest AG Management Board

Management Board Biotest AG Product Development Jörg Schüttrumpf Grifols Group
PRESS RELEASE

published on 08/28/2024 at 09:00, 1 year 3 months ago

Dr. Jörg Schüttrumpf resigns from the Management Board of Biotest AG
Dr. Jörg Schüttrumpf resigns as Chief Scientific Officer of Biotest AG to focus on role as Chief Scientific Innovation Officer of Grifols Group, effective August 31, 2024

Resignation Management Board Biotest AG Grifols Group Dr. Jörg Schüttrumpf
BRIEF

published on 08/06/2024 at 09:05, 1 year 3 months ago

Biotest Sees 35% Sales Spike in First Half of 2024

Financial Results Revenue Growth FDA Approval Biotest Yimmugo®
PRESS RELEASE

published on 08/06/2024 at 09:00, 1 year 3 months ago

Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
Biotest AG reports 35% sales increase to Euro 372 million in H1 2024. EBIT reaches Euro 78.4 million. FDA approves Yimmugo® and BNL facility. Positive revenue and earnings growth

Revenue Growth FDA Approval Sales Increase Biotest AG H1 2024

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 57 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 8 hours 2 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 32 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 27 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 32 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 10:15, 17 minutes ago

Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 52 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 1 hour 2 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 27 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 32 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 47 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 16 hours 32 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 47 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 48 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 3 hours ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health

View all LES ECHOS COMFI WIRE